Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT07215936

Dose-dense Capecitabine Schedule [7days on _7 Days Off] in Colorectal Cancer in Comparison With Standered Regimen

Dose_dense Capecitabine Schedule in colorectal cancers

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Colorectal Cancer Colonic Diseases Colorectal Neoplasms Digestive System Diseases Digestive System Neoplasms Gastrointestinal Diseases Gastrointestinal Neoplasms Intestinal Diseases Intestinal Neoplasms Neoplasms Neoplasms by Site Rectal Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

Sohag university hospital

Sohag, Egypt

About this study

Dose_dense Capecitabine schedule[7 days on_7days off] in colorectal cancer in comparison with standerd regimen

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients who diagnosed colorectal cancer Performance status ranging from 0 to 2 Both sexs

Exclusion criteria

  • pateints with other malignancy Pateints who have other comorbid diseas

Treatment and study plan

Arm A:Dose_dense Capecitabine in Colorectal cancer

Drug

Appling dose _dense Capecitabine 1750mg/m2 for one week then one week off Cycle repeated every 2 weeks

Arm B : standard dose Capecitabine

Drug

Pateints will receive capecitabine 1000 mg/m2 for 2 weeks then one week off

Primary outcomes

  1. 1_Quality of life assessed through EORTC_QLQ_CR29 questionaire

    Time frame: 2 years

Sponsors and collaborators

Lead sponsor

Sohag University

Other

Registry information

Official study title

Dose_dense Capecitabine Schedule [7days on _7days Off] in Colorectal Cancer in Comparison With Standered Regimen

Important dates

Study start
2025
Primary completion
2027
Study completion
2028
First posted
Oct 14, 2025
Registry last updated
Oct 14, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.